5032 results for "*oma"

in 28.51 milliseconds.

• Identification of drug resistance genes in melanoma

  Our aim is to analyze the genome of human melanoma cell lines and short term culture from human melanoma samples in order to identify genes that confer drug resistance to clinically relevant targeted therapies. We will perform whole-exome sequencing, copy number variation analysis and methylome analysis in a collection of human melanoma cell lines and short term culture that will be then screened for drug sensitivity/resistance through a library of clinically relevant drugs and drug combinations. By the combined analysis of the genomic lesion and the drug sensitivity/resistance profile of different cell lines, we will look for genes whose mutation is associated to the sensitivity or resistance to a specific drug in different samples.

  Dataset EGAD00001001124

• BLUEPRINT release January 2015, Bisulfite-Seq for Multiple myeloma

  Bisulfite-Seq data for 2 Multiple myeloma sample(s). 16 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811

  Dataset EGAD00001001152

• BLUEPRINT transcriptional profiling of normal and neoplastic plasma cells

  RNAseq profile of purified plasma cells from multiple myeloma patients and tonsils of healthy donors

  Dataset EGAD00001001212

• Myeloma Targeted Follow-up Study

  Targeted sequencing follow-up of genomic lesions in multiple myeloma.

  Dataset EGAD00001001215

• Chordoma Extension Study

  Extension analysis to pursue candidate genes of interest in chordoma

  Dataset EGAD00001001238

• Chordoma Extension (known cancer genes)

  Extension analysis to pursue candidate genes of interest in chordoma

  Dataset EGAD00001001239

• WES of HCC

  WES of HCC by HiSeq 2000,total 71 samples including Hepatocellular carcinoma cell lines and nornal sample(Peripheral Blood or the adjacent tissues of cancer)

  Dataset EGAD00001001249

• Mesothelioma Whole Genomes

  Genomic architecture of mesothelioma parent study is project 925. This project is set up in parallel to project 925 in order to Whole genome sequence ten of the 59 tumours in that project.

  Dataset EGAD00001001265

• Primary angiosarcoma Whole Genome Sequencing

  Whole genome sequencing of primary angiosarcoma

  Dataset EGAD00001001266

• Anaplastic Meningioma WGS-X10

  Anaplastic meningiomas are a rare, malignant variant of meningioma. At present there is no effective treatment for this cancer. The aim of the study is to identify somatic mutations in anaplastic meningiomas. We plan to sequence a set of 500 known cancer genes in 50 anaplastic meningioma and corresponding peripheral blood DNA samples. Bioinformatics will be used to analyse the results to assess the probability of these mutations being causal and so likely of critical importance for the tumour growth. Identification of these mutations will guide selection of appropriate compounds to effectively treat the disease.

  Dataset EGAD00001001267